|
To learn more about MyBeiGene, click here.
• Coherus Solutions
• Incyte Cares
• Mirati & Me Details >
Stay current on new, retired, and revised policies/articlesDetails >• Delayed Pass-Through and Periodic Interim Payments
• Updated Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• CMS will implement G2211 in 2024
• CMS Accountable Care Organization Initiatives in 2024
• Increase Access to Sickle Cell Disease Treatments
• MLN Matters
• And More Details >New 2024 Resources & Webpages on QPP WebsiteDetails >This edition includes articles on• Latest on the No Surprises Act
• Physician, Hospital, & Payer Working Together for the Patient
• Enhancing Medicare Advantage Transparency
• The Impact of Poverty on Health-Related Outcomes
• Feds Signal Intent for MA Overhaul Details >
Recent Oncology Related News• Approval Letters to Commercial Inpatient Auths
• Rejected Blue Cross Complete Claims
• Additional Fee Schedules Added to Provider Portal
• We’re Reprocessing BCN Claims That were Denied for QVJ Code Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 1-17-24• New! Denials for maintenance Retacrit/Procrit
• Drug Reimbursement for MVASI
• BCBSM Carelon Dismissal Notes Details >Last Reviewed/Updated 2-16-24• BCBSM Medicare Plus Blue Denying J9190
• Optum Denials Preparation & Administration of Drugs Details >• HEDIS® Medical Record Review MY2023 Coming Soon!
• Keep Provider Information Updated in NPPES
• Prior Auth & Benefit Coverage Policy Updates
• Medical Record Review Projects Details >• Medicare Preauthorization & Notification List Changes
• Commercial Preauthorization & Notification List Changes
• Injectable Drugs & Biologics Step Therapy Requirement
• Humana Q1 2024 Newsletter Details >Recent Oncology Related News• Molina Will Exclusively Utilize the Availity Portal for Provider Needs Details >• Incentive Programs
• DBM Program
• Cost Estimator No Longer Includes Estimates for Medicare
• 2024 PriorityMedicare D-SNP MOC Provider Training
• And More Details >• Medical Policy Updates
• Reimbursement Policy Updates
• Special Medical Injectable Drug Program Updates
• Pharmacy & Clinical Updates Details >
• AstraZeneca Tagrisso
• EMD Serono Tepmetko
• Ipsen Onivyde
• Janssen Balversa
Details > • Pfizer's ELREXFIO (elranatamab-bccm) Granted Injection Pass-Through for Hospital OPPS & Assigned a HCPC C-Code
• Pfizer's ELREXFIO (elranatamab-bccm) Assigned a HCPCS J-Code Details >
February 2024 Frequently Asked Questions• Concurrent vs. Sequential Infusions
• Billing 9641X Codes
• Documentation for Medically Necessary Fluid Replacement Details > |
